Covid-19 vaccine-maker BioNTech to acquire former rival CureVac

www.politico.eu

Covid-19 vaccine-maker BioNTech to acquire former rival CureVac

www.politico.eu

News BotMB to

POLITICO EuropeEnglish · 2 days ago

Both German companies have continued mRNA programs on so-called cancer vaccines.

You must log in or # to comment.

Chat

POLITICO Europe

PoliticoEurope

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !PoliticoEurope@metawire.eu

Community locked: only moderators can create posts. You can still comment on posts.

DISCLAIMER: POLITICO is privately owned by Axel Springer SE in Germany. The same company that publishes BILD and WELT. They are often considered sensational.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

6 users / day
67 users / week
222 users / month
461 users / 6 months
2 local subscribers
19 subscribers
1.6K Posts
76 Comments
Modlog